Khaw et al. tested a different approach to enhance tumor specificity by conjugating DOX to a polymer functionalized with DTPA to form a polymer prodrug conjugate that can bind to previously injected bsAbs directed against HER2 and DTPA [133]. This evidence concerns the gene ERBB2 and neoplasm.